慢病毒载体诱导小型猪脊髓低级别胶质瘤模型
研究在既往小型猪高级别脊髓胶质瘤模型基础上,通过椎管内慢病毒注射PDGFB联合TP53敲低(组1)或再加BRAF V600E(组2),每组4只,观察180天。两组均出现组织学低级别表型,肿瘤穿透率100%(8/8),行为缺陷轻微且多为一过性,仅2/8符合MRI标准。结论提供低级别脊髓胶质瘤小型猪模型的概念验证。
要点
- 椎管内慢病毒递送PDGFB联合TP53敲低可在小型猪诱导组织学低级别脊髓胶质瘤。
- 组织学肿瘤穿透率为100%(8/8),行为缺陷轻微且多为一过性。
- 仅2/8动物符合MRI标准,其中1例见强化髓内占位,提示影像检出有限。
核心结论
- 数据提供小型猪低级别脊髓胶质瘤模型的概念验证,可作为研究低级别胶质瘤生物学的大型动物平台。
研究设计与样本
- 两组小型猪(每组N=4)接受椎管内慢病毒注射:组1靶向PDGFB联合TP53敲低,组2为PDGFB、BRAF V600E联合TP53敲低。
- 按预设方案仅对持续步态异常动物行MRI,所有动物在固定180天终点行终末组织病理学检查。
主要发现
- 两组均形成组织学低级别表型的脊髓病变,与既往高级别模型不同。
- 组织病理学肿瘤穿透率为100%(8/8)。
- 组1病变呈弥漫浸润性,肿瘤细胞均匀,伴组织水肿,无坏死或血管增生,符合低级别星形细胞表型。
- 组2病变呈异质性双相形态,兼有弥漫胶质瘤成分和梭形细胞成分,核异型性增加。
- 行为缺陷轻微且多为一过性;2/8动物符合MRI标准(均属组2),其中1例发现强化髓内占位。
临床怎么用
- 该模型可用于在临床相关体型动物中研究低级别脊髓胶质瘤的生物学与治疗策略。
- MRI在低级别病变中检出有限,提示模型评估需结合组织病理学。
局限性
- 样本量小(每组N=4),需更大队列验证。
- 缺乏前瞻性间隔影像学评估。
- 需与人类脊髓胶质瘤数据集进行分子验证以确立转化保真度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Spinal cord gliomas span a broad biological spectrum, from aggressive high-grade to indolent low-grade tumors, yet clinically relevant large animal models of low-grade disease remain scarce. Building on our established minipig high-grade spinal cord glioma model (lentiviral delivery of PDGFB, HRAS, and TP53), we sought to develop a complementary low-grade model on the same platform. METHODS: Two cohorts of minipigs (N=4 per group) received intraspinal lentiviral injections targeting PDGFB with TP53 knockdown (Group 1) or PDGFB, BRAF V600E, and TP53 knockdown (Group 2). Per a pre-specified protocol, MRI was performed only in animals with persistent altered ambulation; all animals underwent terminal histopathology at a fixed 180-day endpoint. RESULTS: Both groups developed spinal cord lesions with a histologically low-grade phenotype, in contrast to our previously characterized high-grade model. Histopathologic tumor penetrance was 100% (8/8). Group 1 lesions were diffusely infiltrative, with uniform tumor cells, tissue edema, and no necrosis or vascular proliferation, consistent with a low-grade astrocytic phenotype. Group 2 lesions showed heterogeneous, biphasic morphology combining diffuse gliomatous and spindle-cell components with increased nuclear atypia. Behavioral deficits were mild and largely transient; 2 of 8 animals met MRI criteria (both Group 2), and a mass-forming, contrast-enhancing intramedullary lesion was identified in 1. CONCLUSIONS: These data provide proof-of-concept for a minipig model of low-grade spinal cord glioma, offering a clinically scaled large animal platform for studying low-grade glioma biology. Larger cohorts, prospective interval imaging, and molecular validation against human spinal cord glioma datasets are needed to establish translational fidelity.
引用
- Lei K, Mela A, Federici T, et al. Lentiviral Vector-Induced Modeling of Low-Grade Glioma in the Minipig Spinal Cord. World Neurosurg. 2026. PMID: 42951074. doi:10.1016/j.wneu.2026.125456
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。